Staud L, Pflug B
Neurologischen Klinik, Bad Homburg.
Psychiatr Prax. 1992 Jul;19(4):114-8.
The neuroleptic malignant syndrome is a potentially lethal consequence of treatment with neuroleptics. It is possible that a patient, suffering from neuroleptic malignant syndrome now, had no such illness in the past, while being treated with neuroleptics; furthermore he may respond well to rechallenge with the original agent in the future. The malignant neuroleptic syndrome of a 29 year old man, whom we treated with benperidole, is described. The course of the disease and the differential-diagnosis is stated. The ways of treatment with bromocriptine, dantrolene sodium and amantadine, as described in the literature, are presented. As the neuroleptic malignant syndrome ist rare many cases should be collected in order to enhance the knowledge of the etiology and the pathogenesis of that life--threatening complication of treatment with neuroleptic drugs.
抗精神病药物恶性综合征是使用抗精神病药物治疗可能导致的致命后果。目前患有抗精神病药物恶性综合征的患者,在过去接受抗精神病药物治疗时可能并无此病;此外,他未来再次使用原药物时可能反应良好。本文描述了一名29岁男性使用苄哌利多治疗后出现的恶性抗精神病药物综合征。阐述了疾病的病程及鉴别诊断。介绍了文献中所述的使用溴隐亭、丹曲林钠和金刚烷胺的治疗方法。由于抗精神病药物恶性综合征较为罕见,应收集更多病例以增进对这种抗精神病药物治疗危及生命并发症的病因及发病机制的认识。